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Contamination of recreational waters with cyanobacterial toxins continues to increase 
and presents a risk to animals and humans. Although cases of acute hepato- and 
neurotoxicoses in dogs following cyanotoxin exposure exist, no reports of skin-related 
reactions in dogs exist. A 5-year-old female spayed 34 kg Bracco Italiano was initially 
presented for rapid onset of severe pruritus and urticaria. Marked excoriation and 
erythema were noted over the chest and neck, while urticaria was noted in the inguinal 
regions and ventral abdomen. Initial basic dermatology work-up excluded parasitic, 
fungal, and bacterial organisms. Due to the severity and progression of urticaria, 
the dog received IV dexamethasone and IM diphenhydramine. Improvement of the 
urticaria and the dog’s clinical status was noted over the next 45 min. Assessment 
of the dog’s environment revealed access to a lake on the property with visible algal 
bloom. Water from the lake was submitted for toxicology testing and revealed the 
presence of debromoaplysiatoxin. Access to the lake was discontinued and follow-up 
evaluation over the next few weeks revealed a complete resolution of the skin irrita-
tion. To the authors’ knowledge, this is the first case report of debromoaplysiatoxin 
exposure in a dog after swimming in cyanobacteria-contaminated water. Veterinarians 
should recognize the potential harm that contaminated waters may cause in terms of 
dermal, hepatic, and neurological conditions. In addition, more prudent oversight of 
contaminated recreational waters is recommended for animals and humans to prevent 
adverse events and intoxications.
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INtRoDUCtIoN
Cyanobacteria poisoning in dogs is not a new phenomenon. Most reports document exposure to 
hepatotoxic microcystins (1–4) and neurotoxic anatoxin-a (5, 6). In contrast, documentation of the 
Abbreviations: IM, intramuscular; IV, intravenous; NPO, nil per os, withhold oral intake of food and fluids; PO, orally; PRN, 
pre re nata, when necessary; Q, every.
FIGURe 1 | Mat-forming algal bloom along the shore of the lake the 
dog accessed.
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irritant and allergenic effects of cyanotoxins is limited with most 
reports referring to studies in laboratory animals (7, 8) or epi-
demiological studies in humans (9–12). Although skin irritation 
after exposure to recreational waters is routinely mentioned as a 
health risk, a majority of effort has been focused on the association 
between total coliform, fecal coliform, and E. coli and skin-related 
symptoms (13) and not cyanobacteria. Dermatotoxins produced 
by cyanobacteria have been linked to outbreaks of skin irritation 
and include aplysiatoxins, debromoaplysiatoxins, and lyngbya-
toxins. However, cyanobacterial dermatotoxins were not widely 
recognized until the late 1950s when an epidemic of acute contact 
dermatitis was reported in bathers along the beaches of Oahu, 
Hawaii (14). Exposure to Lyngbya majuscula was suspected and 
studies using purified extracts from L. majuscula positively iden-
tified exposure to this cyanobacterium as the inciting cause (15). 
Nevertheless, it would take more than a decade before the exact 
toxin, debromoaplysiatoxin, was isolated and identified (16). 
Unfortunately our understanding of cyanobacteria-associated 
dermatologic illnesses from exposure to freshwater is lacking with 
most acute dermatitis studies focusing on marine cyanobacteria 
such as the Hawaii epidemic.
A 2006 review of anecdotal and case reports and epidemiologi-
cal studies of recreational and occupational exposure to freshwater 
cyanobacteria found that the true incidence of acute cyanobacteria-
associated illness is unknown, likely due to under-recognition and 
under-diagnosis by healthcare providers (10). As our understand-
ing of the toxins associated with cyanobacteria increase and our 
ability to detect the various toxins in biologic samples expand, 
linking exposure to illness will become easier. In addition, given 
the association between increasing temperatures and increased fre-
quency of cyanobacteria blooms around the world, the incidence of 
cyanobacteria-associated illness will likely increase (17). Changing 
climates and anthropogenic activities are also likely to have an 
impact; therefore, healthcare providers and veterinarians will have 
to be vigilant when it comes to evaluating all aspects of adverse 
outcomes to cyanotoxins from recreational waters.
Case pReseNtatIoN
Within 24  h of swimming in a lake in Northern California, a 
5-year-old, 34-kg, spayed female Bracco Italiano developed 
severe pruritus, urticaria, and malaise and presented to the VCA 
Sacramento Veterinary Referral Center (SVRC) for evaluation. 
On evaluation, a large area of excoriation with erythema was 
noted over the cranial chest and at the base of the neck. In addi-
tion, the pinnae were erythematous and there was frequent head 
shaking by the dog. On otoscopic examination, the tympanic 
membranes were intact with only a small amount of cerumin 
noted; no erythema was seen within the canals. The dog’s vulva 
was also thickened and erythematous with urticaria noted on the 
skin adjacent. Urticaria was evident in the inguinal regions and 
ventral abdomen and appeared to progress during the physical 
evaluation. A skin scraping of the cranial thorax revealed no 
evidence of parasites. An impression smear, also of the cranial 
thorax, revealed degenerate neutrophils, a few eosinophils, and 
no bacteria or fungal organisms. No fungal organisms or bacteria 
were found on cytology of the ear.
Due to the progression of urticaria over the inguinal region, 
ventral abdomen, and shoulders during the initial evaluation, a 
hypersensitivity reaction to an unknown stimulus was suspected. 
The dog was given dexamethasone SP (0.02  mg/kg IV) and 
diphenhydramine (2  mg/kg IM) and kept for observation for 
the next 45 min. During that time, the urticaria appeared to be 
resolving, although there was still some residual erythema along 
the cranial thorax and the head shaking continued. Concern 
by the owner for the possibility of blue-green algae intoxica-
tion prompted the collection of blood for selected chemistries, 
CBC, and venous blood gas analysis. Abnormalities were only 
identified on the CBC and consisted of a mild neutrophilia 
(12,940 cells/μL; ref range: 3,000–10,500  cells/μL). The dog 
was discharged on cephalexin (1000 mg PO q 12 h × 14 days), 
prednisone (30 mg PO q 12 h for 7 days, followed by tapering 
to q 48 h for 7 days), and diphenhydramine (75 mg PO q 8–12 h 
PRN × 5 days). Referral to a dermatology clinic was also recom-
mended if the erythema and head shaking continued. Overnight, 
the dog vomited several times and developed diarrhea. She was 
presented to VCA SVRC the next morning and continued to 
vomit bile and was inappetent. On physical examination, the 
dog was alert, eupneic, dehydrated, and the abdomen palpated 
as non-painful. Due to the recent history of hypersensitivity 
reaction, GI shock was considered the most likely cause for 
vomiting and diarrhea; however, other underlying causes were 
also considered especially because of the dog’s previous history of 
eosinophilic and lymphocytic-plasmacytic enteritis. The owner 
elected inpatient care consisting of the administration of LRS (on 
a 5% rehydration rate over 6 h, IV), famotidine (1 mg/kg, IV, q 
24 h), metronidazole (10 mg/kg, IV, q 12 h), dolasetron (0.6 mg/
kg, IV, q 24 h), and diphenhydramine (2 mg/kg, IM, TID). She 
was also placed on NPO before being referred to the VCA critical 
care unit for further monitoring, where clinical improvement was 
noted over the next 48  h. The dog was sent home after 2  days 
of hospitalization. Follow-up evaluation after 1 week revealed a 
complete resolution of clinical signs.
FIGURe 4 | Anabaena/Trichormus sp. identified in the lake water. Only 
one colony of filaments was observed in the sample. Akinetes, important 
characteristics morphological features were not present which prevented 
further identification to the lowest possible taxonomic level. Wet mount of 
lake water, ×400 (scale bar = 20 µm).
FIGURe 3 | Lyngbya sp. identified in the lake water. Filamentous 
cyanobacteria with a thin, colorless sheath. Wet mount of lake water, ×400 
(scale bar = 20 µm).
FIGURe 2 | Lake surface covered with a dense growth of Wolffia 
columbiana. W. columbiana is a small, free-floating aquatic plant commonly 
known as watermeal and native to California. Watermeal is non-toxic and 
thrives in nutrient-rich water, conditions suitable for cyanbacteria growth and 
toxin production.
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Careful evaluation of the dog’s environment revealed access 
to several lakes with visible algal bloom (Figures 1 and 2). Water 
from the lake the dog had access to prior to developing illness 
was submitted for phycological and toxicological evaluation. 
Microscopic observation of the water sample (Green Water 
Laboratories/Cyanolab, Palatka, FL, USA) showed a dominant 
presence of a tiny vascular plant Wolffia columbiana (common 
name: watermeal), a high density of motile bacterial rods and 
bacterial filaments, and an abundant filamentous cyanophyte 
called Microchaete cf. uberrima. The water sample also contained 
green algae (Chlorophyta) and diatoms (Bacillariophyta). Specific 
to cyanobacteria, the water sample contained Microchaete 
cf. uberrima, Lyngbya sp. (Figure  3), Pseudanabaena sp., 
Anabaena/Trichormus sp. (Figure 4), Microchaete sp., Scytonema 
sp., Calothrix sp., and Aphanothece elabens. Amongst the cyano-
bacteria identified, only Anabaena/Trichormus sp. and Lyngbya 
sp. were of toxicological significance. Unfortunately, positive 
species identification for Anabaena/Trichormus sp. and Lyngbya 
sp. could not be achieved from collected specimens.
The water samples were also analyzed for cyanotoxins by 
LC-MS/MS (Green Water Laboratories/Cyanolab, Palatka, 
FL, USA and the California Animal Health and Food Safety 
Laboratory, University of California, Davis, CA, USA). The water 
contained 3.8  µg/g debromoaplysiatoxin [limit of detection 
(LOD) 0.3 µg/g]. The water also contained a low concentration of 
anatoxin-a that was estimated to be 1 µg/L. The water contained 
no aplysiatoxin (LOD 0.5 µg/g), lyngbyatoxin-a (LOD 0.2 µg/g), 
or cylindrospermopsin (LOD 1 µg/L).
DIsCUssIoN
The current case study confirms a case of debromoaplysiatoxin 
poisoning in a dog following access to contaminated lake water 
and highlights the potential for serious skin irritation after 
cyanotoxin exposure. While most of the toxic cyanobacteria are 
freshwater species, the first documentation of algal toxin-induced 
dermatitis dates back to 1958 when swimmers along the beaches 
of Oahu, Hawaii, developed acute, vesicular contact dermatitis 
(14). A similar outbreak in 1976 again on the shores of Oahu, 
Hawaii was referred to as “swimmers’ itch” (18). In the past dec-
ade, numerous outbreaks in swimmers have occurred in Australia 
and Hawaii (19, 20). Clinical findings in people include gradual 
itching and burning progressing to reddening and swelling of the 
skin with blister formation especially in areas covered by a bath-
ing suit, where the seaweed/toxins are trapped. Desquamation of 
blisters can lead to skin erosions. The dermatitis typically resolves 
completely within 1  week. In more severe cases, symptomatic 
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treatment with analgesics, antihistamine, and steroids is provided. 
Lyngbya dermatitis can develop after only minutes of exposure to 
contaminated waters; airborne contact dermatitis on faces has 
also been noted during weather patterns with strong winds. The 
dog in this case developed severe pruritus and urticaria within 
24 h of swimming in contaminated lake water. Prompt treatment 
with dexamethasone and diphenhydramine prevented progres-
sion to a more severe dermatitis. Within 1 week, the dog’s skin 
condition had resolved completely.
Isolation of the actual dermatotoxins from L. majuscula and 
from the digestive gland of the sea hare Stylocheilus longicauda 
occurred in the early 1970s (21, 22). Subsequent toxicity studies 
with debromoaplysiatoxin in laboratory animals and human 
volunteers confirmed this compound to be a potent primary skin 
irritant (23). Mice and rabbits developed erythema, edema, and 
sloughing of skin within 6 h of topical application of a 0.05% debro-
moaplysiatoxin solution. Human volunteers described tingling 
and burning sensation after application and developed an irritant 
pustular folliculitis between 6 and 12 h of topical administration 
that required up to 10  days to resolve. Debromoaplysiatoxin 
was subsequently isolated from other tropical marine cyano-
bacteria including Lyngbya gracilis, Oscillatoria nigroviridis, and 
Schizothrix calcicola (16). In the freshwater environment, the 
filamentous, benthic cyanobacterium Lyngbya wollei is now the 
cause for common proliferations in lakes and rivers from the 
St. Lawrence/Great Lakes basin to Florida (24). In the lake sample 
collected for this case work-up, the presence of Lyngbya sp. was 
confirmed by phycological evaluation. Unfortunately, only one 
colony of filaments was observed in the presence, which did not 
allow for species identification. The finding of Lyngbya sp. in 
the lake water is not surprising, considering L. wollei has been 
recorded in three sites of California streams (25). L. wollei has 
the ability to produce a wide range of toxins including paralytic 
shellfish toxins, and hepatotoxic cylindrospermopsin and its 
derivatives (26). Currently, it is unclear whether L. wollei is 
capable of producing dermatotoxins. Interestingly, most recent 
review articles provide in-depth information on the neuro- and 
hepatotoxicity of cyanotoxins but highlight the need for further 
examination of dermatotoxins because they bear major potential 
public health consequences for recreational users, while there are 
very limited toxicity and geographic distribution data available 
(27–29). In addition to debromoaplysiatoxin, aplysiatoxin and 
lyngbyatoxins have been associated with skin irritation (30). 
A debromoaplysiatoxin-producing Lyngbya bloom that occurred 
in the Homosassa River in 2008 was hypothesized as the cause for 
ulcerative dermatitis in manatees (31). Thus, while debromoaply-
siatoxin is predominantly detected in marine water, one report 
documents its occurrence in freshwater ecosystems in Florida. Our 
report adds additional occurrence data of debromoaplysiatoxin in 
freshwater and is the first documentation of debromoaplysiatoxin 
in freshwater from a Northern California lake resulting in skin 
irritation in a dog. Debromoaplysiatoxin produced dermatitis 
on the murine ear at 0.005 nmol (equivalent to 2.7 ng) per ear 
(32). Considering an estimated biomass of 30 mg/L dry weight 
in the lake water, 1 L of water would have contained 114 ng of 
debromoaplysiatoxin. Based on the limited toxicity data available 
for topical exposure, the concentrations found are considered to 
be capable of resulting in dermal irritation. The lake water con-
tained no detectable amounts of aplysiatoxin or lyngbyatoxin-a. 
Debromoaplysiatoxin, aplysiatoxin, and lyngbyatoxins exert their 
toxic effects by binding and activating protein kinase C isozymes 
(33). PKC belongs to a family of serine/threonine kinases and 
plays important roles in cellular signaling transduction for pro-
liferation, differentiation, and apoptosis (34); activation of PKC 
can induce cutaneous inflammation (35). Debromoaplysiatoxin 
and its brominated analog aplysiatoxin can also cause diarrhea 
in animals and humans (36, 37). The dog developed diarrhea and 
vomiting approximately 48 h after swimming in the lake. These 
gastrointestinal signs could have been a direct toxic insult of 
debromoaplysiatoxin on the intestine similar to what has been 
confirmed after oral administration of aplysiatoxin to mice (38). 
However, because of the dog’s previous history of eosinophilic 
and lymphocytic-plasmacytic enteritis, other underlying causes 
were also considered.
It is important to consider the role of anatoxin-a in the clinical 
presentation of this dog since anatoxin-a was detected in the lake 
water sample. Anatoxin-a is a potent cholinergic agonist at nico-
tinic acetylcholine receptors in neurons and at the neuromuscular 
junctions and can lead to muscle tremors and, in severe cases, sei-
zures and respiratory paralysis (6, 39). The toxin is produced by 
many different cyanobacteria including as Anabaena, Plantkothrix, 
Oscillatoria, Microcystis, Aphanizomenon, Cylindrospermum, and 
Phormidium sp. Anatoxin-a has been found in rivers and lakes 
in CA (39). Anabaena/Trichormus sp. was identified in the water 
sample; due to lack of akinetes in the sample, further identifica-
tion to the species level was not possible. However, the fact that 
anatoxin-a was identified in the water sample is a clear indication 
of the presence of a toxin producer. Fortunately, the dog did not 
develop neurologic signs, which is likely attributable to exposure 
to a dose below the toxic threshold. In other reported anatoxin-a 
poisoning cases, values of anatoxin-a ranging from 0.01 mg/L to 
1 mg/L were detected (6, 39). In contrast, an estimated concentra-
tion of 1 μg/L was found in this case. This finding highlights the 
importance of toxicological evaluation of suspect water sample. 
While phycological examination of a water sample aids in the 
diagnostic approach of a suspect cyanotoxins exposure, it is 
important to note that the production of toxins by cyanobacteria 
is strain specific, and morphological observations alone cannot 
predict the hazard level. Thus, detection of toxins is needed to 
confirm a suspect intoxication.
CoNCLUDING ReMaRKs
This study adds an additional toxin, debromoaplysiatoxin, to the 
list of freshwater toxins resulting in acute illness in animals. The 
presence of debromoaplysiatoxin in recreational waters has health 
implications for pets and humans using environments containing 
high concentrations of this cyanotoxin. Our investigation offers 
insight into the dermatotoxic risk from cyanotoxin exposure in 
companion animals, as well as the risk for co-exposure to mul-
tiple toxins and a complex clinical presentation. To the authors’ 
knowledge, this is the first documentation of debromoaplysia-
toxin-induced skin irritation in a dog. Owners and veterinarians 
should recognize the potential harm in allowing dogs to access 
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cyanobacteria-contaminated waters. If adverse effects are noted, 
access to water must be denied, and supportive care should be 
initiated. In addition, more prudent oversight of recreational 
waters is recommended to prevent adverse events/intoxications 
not only for companion animals but also for humans.
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